Psoriasis: Treatments, Psoriatic Arthritis, Diet and Evidence-Based Skin Care

Evidence reviewed: 8 November 2026. Psoriasis is a chronic immune-mediated inflammatory disease affecting the skin and sometimes nails and joints. It commonly produces well-demarcated, scaly plaques, but can also affect the scalp, skin folds, palms, soles or nearly the entire body. Treatment has advanced well beyond topical creams: appropriate options include topical medicines, phototherapy, oral systemic treatments and targeted biologics. A healthy diet can support cardiometabolic health, but no specific food, supplement or “detox” has been proven to cure psoriasis [1–3].

What causes psoriasis?

Psoriasis involves dysregulated immune signaling, particularly the IL-23/Th17/IL-17 pathway, with contributions from tumor necrosis factor and other mediators. These signals accelerate keratinocyte turnover and produce the characteristic inflammatory plaques. Genetic predisposition matters, but inflammation also interacts with environmental factors. Psoriasis is not contagious and cannot be transmitted by touching affected skin [1].

Some patients experience flares associated with skin injury (the Koebner phenomenon), infections, smoking, heavy alcohol use, stress or certain medicines. These associations vary; not every flare has an identifiable trigger, and psoriasis does not reflect poor hygiene.

Symptoms and common forms

  • Plaque psoriasis: raised, sharply outlined patches with scale, often on elbows, knees, scalp or lower back.
  • Scalp psoriasis: persistent thick scaling and itching that can extend beyond the hairline.
  • Inverse psoriasis: smooth, inflamed patches in skin folds, where heavy scales may be absent.
  • Guttate psoriasis: numerous small lesions, sometimes appearing after a streptococcal infection.
  • Nail psoriasis: pitting, discoloration, thickening or separation from the nail bed.
  • Pustular or erythrodermic psoriasis: uncommon potentially severe forms that can cause systemic illness and require urgent assessment.

Redness may be less obvious in darker skin, where plaques can appear violet, gray, dark brown or hyperpigmented. Persistent discoloration after inflammation settles does not necessarily mean that active plaques remain. Severe widespread redness, fever, dehydration or painful extensive pustules requires emergency medical care.

Is psoriasis only a skin condition?

No. Psoriasis is associated with psoriatic arthritis and an increased burden of obesity, hypertension, diabetes, cardiovascular disease, depression and other conditions. The associations do not mean every patient will develop these disorders, but they support regular assessment of overall health [1,2].

Ask about morning joint stiffness, persistent joint swelling, heel pain, a swollen entire finger or toe (dactylitis), or inflammatory back pain. Patients with suspected psoriatic arthritis should be referred for rheumatology assessment because untreated joint inflammation may cause irreversible damage. A skin cream will not adequately treat active destructive joint disease [1].

How is severity assessed?

Clinicians consider body surface area (BSA), physician assessment, symptoms, location and effect on daily life. A small plaque in a sensitive area such as the face, genitals, hands or soles can cause severe impairment despite limited BSA. The Psoriasis Area and Severity Index (PASI) is widely used in research and treatment assessment, while BSA and patient-reported quality-of-life measures may be more practical in routine care [1].

Severity determines whether topical treatment is sufficient or systemic therapy or phototherapy should be discussed. A person’s preferences, pregnancy plans, infections, other illnesses and treatment access also matter.

First-line treatments for limited plaque psoriasis

The American Academy of Dermatology–National Psoriasis Foundation (AAD–NPF) guidelines recommend topical corticosteroids for many cases of plaque psoriasis outside sensitive skin areas. These reduce inflammation and thickness, but potency and duration should match the site and patient [1].

Topical treatment Role Important cautions
Corticosteroids Often effective for plaques and itch; stronger preparations may be prescribed briefly for thick areas. Overuse can thin skin; face, folds and genitals need especially careful selection.
Vitamin D analogues such as calcipotriol/calcipotriene Help regulate keratinocyte differentiation; may be combined with topical corticosteroids. Can irritate; not identical to taking oral vitamin D supplements.
Calcineurin inhibitors, such as tacrolimus or pimecrolimus Sometimes used off-label in sensitive areas, especially face and folds. May sting; clinician-directed use is important.
Roflumilast or tapinarof creams Nonsteroidal options approved in certain regions for eligible plaque psoriasis patients. Product-specific age, site and tolerability considerations.
Emollients and selected keratolytics Reduce dryness and some scale, supporting comfort and drug application. Adjuncts rather than substitutes for anti-inflammatory therapy in significant disease.

Oral vitamin D tablets are not interchangeable with topical vitamin D analogues. Appropriate corticosteroid treatment may be intermittent or combined with steroid-sparing agents under supervision, rather than continuous high-potency application for months [1].

Phototherapy for more extensive disease

Supervised narrowband UVB phototherapy is an established option for selected patients whose disease is too widespread or persistent for simple topical care. It involves controlled ultraviolet exposure at clinical doses, with attention to skin type, cumulative exposure, travel requirements and cancer risk. Commercial tanning beds and deliberate sunburn are not substitutes for medically supervised phototherapy [1].

Phototherapy may be used on its own or alongside medicines; other modalities are selected according to the patient’s condition and local expertise.

Systemic therapies: when topical treatment is not enough

Patients with moderate-to-severe psoriasis, major quality-of-life impairment, difficult sites or active psoriatic arthritis may need systemic treatment. Selection requires individual assessment and monitoring [1,2].

Systemic treatment Role and precautions
Methotrexate Can treat skin and some joint manifestations; requires blood count, liver and kidney monitoring, drug-interaction review and strict pregnancy precautions. Typically prescribed weekly, not daily for inflammatory disease.
Ciclosporin (cyclosporine) May act relatively rapidly in severe disease; kidney function, blood pressure, interactions and duration need monitoring.
Acitretin Oral retinoid for selected psoriasis phenotypes; highly teratogenic with prolonged pregnancy-avoidance requirements.
Apremilast Oral PDE4 inhibitor for eligible patients; can cause gastrointestinal symptoms and weight loss.
Deucravacitinib Selective TYK2 inhibitor approved for suitable moderate-to-severe plaque psoriasis patients in some regions; requires risk and infection review.

These medicines are not interchangeable, and treatment decisions should account for liver disease, renal function, pregnancy, infections, previous treatment and concomitant arthritis. Avoid self-starting systemic corticosteroids for psoriasis; inappropriate use or withdrawal may worsen disease [1].

Biologic treatments: targeted immune therapy

Biologic medicines act on specific inflammatory targets and can achieve substantial skin clearance in many patients with suitable moderate-to-severe disease. Examples include:

  • TNF inhibitors: adalimumab, infliximab, etanercept and other indication-specific agents.
  • IL-17 pathway agents: secukinumab, ixekizumab, brodalumab and bimekizumab in eligible settings.
  • IL-23 inhibitors: guselkumab, risankizumab and tildrakizumab.
  • IL-12/23 inhibitor: ustekinumab.

Drug choice depends on skin and joint involvement, inflammatory bowel disease, other comorbidities, pregnancy plans and risks. Some IL-17 drugs may be less suitable for patients with certain inflammatory bowel disorders, while selected agents may treat both psoriasis and psoriatic arthritis. Before treatment, clinicians review tuberculosis and hepatitis risk, vaccinations and other infection concerns as appropriate. Biologics suppress selected immune pathways and should not be described as a guaranteed permanent cure [1,2].

Can food or supplements treat psoriasis?

Maintaining a balanced diet supports general health and management of cardiovascular risk. Some patients with overweight or obesity may improve psoriasis severity modestly with sustainable weight reduction, particularly alongside effective medical care. However, the AAD–NPF guideline notes insufficient or conflicting evidence to recommend routine fish oil, oral vitamin D, turmeric, zinc, herbal remedies or a gluten-free diet as psoriasis treatment for everyone [1].

Gluten-free eating is not routinely recommended solely because someone has psoriasis. If celiac disease is suspected based on symptoms or other findings, test before removing gluten to preserve diagnostic accuracy. A person with confirmed celiac disease should follow a strict gluten-free diet for that condition, not because the diet has been proven to cure psoriasis.

Reducing excess alcohol, avoiding smoking and improving cardiometabolic health are worthwhile. No high-quality evidence establishes a universal “psoriasis detox,” a specific fasting schedule or large-dose supplements as substitutes for medical treatment [1].

Practical skin-care habits

  1. Moisturize regularly using a fragrance-free product to help with dryness and scaling.
  2. Avoid scratching and picking plaques, which can worsen irritation or lead to infection.
  3. Use topical medicines as directed, especially on thin skin and sensitive areas.
  4. Keep a record of plaque sites, itching, pain, treatment response and joint symptoms.
  5. Seek advice if nail changes, joint swelling or persistent heel pain develop.
  6. Discuss vaccination, infection screening and reproductive planning before systemic therapy.
  7. Address sleep disruption and psychosocial distress; psoriasis can significantly affect quality of life even when plaques appear limited.

What about psoriasis in pregnancy?

Medication choice requires specialist review. Acitretin and methotrexate are contraindicated in pregnancy; some biological agents have different pregnancy and breastfeeding evidence and require individualized decisions. Appropriate moisturizers, selected topical therapy or supervised phototherapy may be considered. Do not stop necessary therapy or change to unverified supplements without a clinician-guided plan.

Frequently asked questions

Can psoriasis spread from person to person?

No. Psoriasis is not contagious.

Is a gluten-free diet the best psoriasis treatment?

No. Current AAD–NPF guidance does not support routine gluten-free eating for all psoriasis patients [1].

Can I use a potent steroid indefinitely on my face?

No. Sensitive skin can develop atrophy and other adverse effects; dermatologists commonly favor lower-potency or steroid-sparing approaches [1].

Is psoriasis related to arthritis?

Yes. Persistent joint swelling, morning stiffness, heel pain or dactylitis may indicate psoriatic arthritis and require assessment.

Do biologics permanently cure psoriasis?

No. Many control disease effectively while used, but treatment response, relapse and adverse effects require monitoring.

Key takeaways

Psoriasis is a systemic immune-mediated disease, not simply dry skin. For localized plaques, appropriate topicals are often effective. Extensive disease may require phototherapy or systemic treatment. Screen for psoriatic arthritis and cardiometabolic conditions; use diet for general health rather than as an unproven cure.

References

  1. American Academy of Dermatology and National Psoriasis Foundation. Joint AAD–NPF guidelines of care for the management of psoriasis. Accessed 8 Nov 2026.
  2. National Institute for Health and Care Excellence. Psoriasis: assessment and management (CG153). NICE; accessed 8 Nov 2026.
  3. National Psoriasis Foundation. About psoriasis and psoriatic disease. Accessed 8 Nov 2026.
  4. American Academy of Dermatology. Psoriasis treatment: medications and care. Accessed 8 Nov 2026.

Medical disclaimer: This article is educational and not a prescription. Systemic immunosuppressants and biologics require clinician-directed selection and monitoring. Severe widespread skin inflammation, fever or significant joint inflammation needs medical assessment.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *